Comparison
20q13 33 Microdeletion Syndrome C4518823 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 20q13 33 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
20q13 33 Microdeletion Syndrome C4518823
A severe chromosomal disorder involving loss of genetic material near the end of chromosome 20. This can result in significant developmental problems and complex medical needs. Requires multidisciplinary supportive care.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
20q13 33 Microdeletion Syndrome C4518823
0-null
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
20q13 33 Microdeletion Syndrome C4518823
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
20q13 33 Microdeletion Syndrome C4518823
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
20q13 33 Microdeletion Syndrome C4518823
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
20q13 33 Microdeletion Syndrome C4518823
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
20q13 33 Microdeletion Syndrome C4518823
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
20q13-33-microdeletion-syndrome-C4518823 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20q13 33 Microdeletion Syndrome C4518823 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Genetic change | Loss of material near the end of chromosome 20. | Extra material from the 15q11q13 region. | High |
| Developmental impact | Source data describe significant developmental problems and complex needs. | Delays, learning difficulties, and sometimes autism-spectrum traits are described. | Moderate |
| Reported severity | Categorized as severe in the supplied source. | Categorized as moderate, with individual variation expected. | Moderate |
When to favor each condition
Choose 20q13 33 Microdeletion Syndrome C4518823 when
Testing identifies a 20q13.33 deletion
The named deletion supports this condition rather than symptom pattern alone.
High
Complex congenital and developmental needs
The source emphasizes significant problems requiring multidisciplinary support.
Moderate
No 15q11q13 duplication is found
Absence of that duplication makes the right condition less likely.
Moderate
Choose 15q11q13 Microduplication Syndrome C2675336 when
Testing identifies a 15q11q13 duplication
The specific duplicated region distinguishes this condition.
High
Learning difficulties or autism traits
These features are described, but they are not specific by themselves.
Low
No 20q13.33 deletion is found
This reduces support for the left condition but does not prove the right one.
Moderate
How key tests differ
| Test | 20q13 33 Microdeletion Syndrome C4518823 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss at 20q13.33. | May show copy-number gain at 15q11q13. | The genomic location and loss versus gain are the main distinction. |
| Clinical genetics review | Correlates the deletion with developmental and medical findings. | Correlates the duplication with development, learning, and behavior. | Clinician interpretation is required; neither result alone defines all features. |
| Developmental assessment | May document significant developmental needs. | May document delays, learning difficulty, or autism traits. | Assessment supports care planning but does not replace genetic confirmation. |
Prognosis comparison
20q13 33 Microdeletion Syndrome C4518823
- Outcome
- A chronic course with potentially substantial support needs is described; individual outcome is not established.
- Factors
- Deletion details, associated medical findings, and access to coordinated care.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- A chronic but often moderate course is suggested; learning and behavioral outcomes vary.
- Factors
- Duplication details, developmental profile, therapies, and educational support.
Time frame: Lifelong, with needs potentially changing across childhood and adulthood.
Prognosis cannot be inferred from the category labels alone and needs clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complexity | Significant developmental problems are described. Delays and learning difficulties are described. Exact complication rates are not established by the supplied data. |
| Behavioral or learning needs | Not specifically established in the source. Autism-spectrum traits may occur in some people. Presence and severity require individual clinical assessment. |
| Medical-care burden | Complex needs and multidisciplinary care are emphasized. Supportive therapies are described for symptom management. No mortality, prevalence, or treatment-dose comparison is established. |
Patient education highlights
- HighGenetic confirmation
Ask a clinician or genetic counselor to explain the exact chromosomal result and its uncertainty.
- HighSupportive care
Care is individualized and may include developmental, educational, and medical support.
- MediumInheritance and transmission
Neither condition is communicable; family implications require genetics counseling.